Summary Cell proliferation rate is a well-established prognostic factor in cancer, but it has not been considered to identify the risk group of childhood acute lymphoblastic leukaemia (ALL) at presentation. We carried out a study to demonstrate the prognostic importance of the rapidity of cell proliferation in patients with ALL. To measure the rapidity of cell proliferation we used the parameter relative to the area of silver-stained nucleolar organiser regions (AgNORs) A combination of these factors allows identification of standard-and high-risk groups, the latter being characterised by less remission and lowest survival rates. Therapeutic protocols applied to children are different according to the group in which they have been included. There is evidence that a more intensive therapy can improve results in the high-risk group. A more precise identification of those children with poor prognostic features should greatly increase the probability of applying more effective therapeutic approaches.
Acute lymphoblastic leukaemia (ALL) is the most frequent tumour of childhood. Using current therapeutic protocols, complete remission is possible in 90% of children, about 70% of whom are alive 5 years later. The most important well-established factors affecting prognosis are leucocyte count, age, cytogenetic abnormalities, leukaemic lymphoblast immunophenotype and sex. A combination of these factors allows identification of standard-and high-risk groups, the latter being characterised by less remission and lowest survival rates. Therapeutic protocols applied to children are different according to the group in which they have been included. There is evidence that a more intensive therapy can improve results in the high-risk group. A more precise identification of those children with poor prognostic features should greatly increase the probability of applying more effective therapeutic approaches.
Cell kinetics has rarely been investigated for prognostic purposes in ALL, in contrast to many other types of human cancers, in which an association between cell proliferating activity and clinical outcome has been found. Cell proliferation rate has not been considered among the prognostic factors for treatment of ALL (Hoelzer et al., 1988; Champlin & Gale, 1989) , probably because of equivocal results obtained regarding the relationship between cell kinetics and prognosis (Murphy et al., 1977; Scarffe, et al., 1980; Dow et al., 1982) . In order to ascertain the prognostic importance of pretreatment cell kinetics measurement in ALL, we evaluated the rapidity of cell proliferation in marrow leukaemic lymphoblasts by measuring the quantity of silver-stained nucleolar organiser regions (AgNOR) proteins. The quantity of AgNOR proteins, a parameter of cell proliferative activity recently introduced in tumour pathology (Crocker, 1990; Derenzini & Ploton, 1991) , has been shown to be directly related to the cell doubling time Derenzini et al., 1990) . For this purpose, smeared marrow preparations from 119 children with ALL were stained, at presentation, with the silver method for the AgNOR proteins (Ploton et al., 1986) Forty-two patients were treated according to AIEOP ALL 87 protocols (Vecchi et al., 1990) while the remaining patients received a different BFM-oriented protocol, called AIEOP ALL 88 (Rossi et al., 1991 NOR silver staining and measurements of interphase AgNORs NOR silver staining was carried out on the cytological samples using a solution of one volume of 2% gelatine in 1% aqueous formic acid and two volumes of 50% silver nitrate (Ploton et al., 1986 Survival (SUR) and event-free survival (EFS) were estimated by the Kaplan-Meier method and updated to June 1992. Time on study or time to terminal event was calculated from the day of diagnosis for both SUR and EFS. Terminal events considered were death from any cause for SUR, and induction death or failure, death in first CR (CCR), and relapse, whichever came first for EFS. The log-rank test was used to assess differences in survival curves (Woolson, 1987) .
Multivariate analysis was conducted according to the proportional hazard Cox regression model (Cox, 1972) to evaluate the relative importance of mean AgNOR area in relation to other known prognostic factors.
Results
In smeared bones marrow blast cells stained by silver, NORs appeared as well-defined black dots, selectively distributed throughout the nucleolar area, and more or less regularly scattered in the lighter stained nuclei. Their quantity was highly variable, independent of the nuclear size of blast cells ( Figures I and 2) .
The mean AgNOR areas of bone marrow cells of the 119 patients ranged from 1.11 to 5.56 jm2; the median and the mean values were 2.37 and 2.43tim2 respectively. The 119 patients were divided into two groups according to their AgNOR values, using a cut-off value of 3 jIm2, which had been previously established as the borderline between rapidly and slowly proliferating tissues . The first group, which we considered to be of low proliferation rate, included 91 children (76%) with a mean AgNOR area of less than 3 jim2 and a median and mean value of 2.11 jm2 (range 1.11-2.95) and 2.10 jIm2 respectively. The second group, which we considered to be of high proliferation rate, included 28 children (24%) with a mean AgNOR area greater or equal to 3 jim2 and a median and a mean value of 3.29 tjm2 (range 3.00-5.56) and 3.51 jim2 respectively. Descriptive statistics relative to the entire population and the two different groups based on a 3.00 jim2 cut-off demonstrated a normal distribution of the mean AgNOR values.
A The comparison between mean AgNOR area and both immunophenotype (T-ALL versus others) and FAB morphology (LI versus L2) revealed significantly higher values of AgNORs in both T-and L2-ALL. No difference in distribution was revealed by Student's t-test according to sex (Table  II) . Nor was a significant association shown between mean AgNOR area and central nervous system leukaemia at onset, nephromegaly, skeletal lesions, massive adenomegaly, initial prednisone response and protocol treatment.
After a median follow-up time of 26 months, the 3 year overall survival (SUR) estimate for the 119 patients was 71.3%. SUR estimate was 85.9% for the group of patients (Hernandez-Verdun, 1983; Goessens, 1984) . Their silver stainability is due to the presence of a specific group of acidic proteins which are necessary for ribosomal RNA synthesis (Howell, 1982) . The quantity of interphase Ag ORs greatly increases in the cell stimulated to proliferate. The maximum AgNOR value is reached during the S-phase (Pession et al., 1991) . In cancer tissues it has been demonstrated that the quantitative distribution of AgNORs is related to the values obtained using other well-established parameters of cell kinetics such as Ki67 LI (labelling index), bromodeoxyuridine labelling index (BrdU LI) and percentage of S-phase cells determined by flow cytometry . Numerous studies carried out on human tumour cells cultured in vitro have shown that the number of AgNORs is strictly and directly related to cell doubling time (Derenzini et al., , 1990 Trere et al., 1989; Hara et al., 1991; Ofner et al., 1992 Other features of the disease, at the time of diagnosis, which have a statistically significative impact on event-free survival of children were, apart from AgNOR value, the immunophenotype and FAB morphology of blasts, the presence of mediastinal tumour mass and leucocyte count. Multiple regression analysis showed that these four parameters are not independent prognostic factors. Only AgNOR value was found to be significantly correlated with the length of event-free survival. This observation is consistent with the correlation between AgNOR value and the single prognostic factors (Table I and II) .
The present findings, obtained from a larger number of patients, were consistent with those reported by Scarffe et al. (1980) and Dow et al. (1982) on the relationship between the proliferative activity of marrow lymphoblasts and the duration of first remission in childhood ALL. These authors found that patients with >6% S-phase cells, measured by either [3H]thymidine incorporation (Dow et al., 1982) or DNA flow cytometry (Scarffe et al., 1980) , had a shorter median length of remission than those <6% S-phase cells. In these studies the cell kinetics parameters represented, together with the WBC count, the most powerful prognostic predictors. In the series of patients considered by us, the WBC count lost its significance in the multiple regression analysis. This might have been due either to different therapeutic regimens reducing the prognostic impact of WBC count or/ and to the fact that in our study the cell kinetics parameter evaluated was not exactly the same as that measured by Scarffe et al. (1980) and Dow et al. (1982) . AgNOR value indicates the rapidity of cell proliferation, which is different from the percentage of S-phase cells. Even if these two parameters have been shown to be statistically related (Crocker et al., 1988; Tanaka et al., 1989; Orita et al., 1990; Trere et al., 1991) , they cannot be considered to be superimposable. The duration of S-phase has been demonstrated to be variable in marrow leukaemic lymphoblasts, and its value has not always been related to the cell doubling time (Nakamura et al., 1991) .
The present findings have demonstrated that cell proliferation is a reliable prognostic parameter in childhood ALL and indicate the opportunity to routinely add cell kinetics evaluation to the other well-established parameters for pretreatment prognostic definition of ALL. Among the methods used for cell kinetics measurement those methods ought to be preferred which evaluate the rapidity of cell proliferation rather than the number of cycling cells. Indeed, it is the former parameter which indicates more precisely the actual growth rate of the neoplastic mass. The importance of the rapidity of cell leukaemic lymphoblast proliferation for the clinical course of ALL can be related to the fact that: (1) if the therapeutic efficacy is the same, the length of the remission would be determined by the degree of cell proliferation rate and (2) drug resistance may develop more quickly in rapidly than in slowly proliferating cells (Scarffe et al., 1980) . Apart from the AgNOR parameter, which has only recently been introduced into tumour pathology for cell kinetics evaluation, cell cycle time length can be precisely measured by DNA flow cytometry (Dolbeare et al., 1983) . This procedure, however, necessitates the in vivo infusion of BrdU and the exclusive utilisation of one whole-bone marrow aspirate. AgNOR quantification is carried out on a smeared preparation using only a small portion of the biopsy material employed for routine characterisation of the leukaemic marrow infiltrate. 
